Vycor Medical, Inc.
VYCO
$0.1179
$0.011310.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.69M | 1.59M | 1.44M | 1.36M | 1.44M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.69M | 1.59M | 1.44M | 1.36M | 1.44M |
| Cost of Revenue | 207.60K | 166.80K | 151.00K | 146.50K | 151.10K |
| Gross Profit | 1.48M | 1.42M | 1.29M | 1.21M | 1.29M |
| SG&A Expenses | 1.41M | 1.36M | 1.31M | 1.23M | 1.21M |
| Depreciation & Amortization | 59.60K | 59.60K | 59.10K | 58.60K | 58.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.70M | 1.60M | 1.53M | 1.44M | 1.44M |
| Operating Income | -12.40K | -9.10K | -92.50K | -82.90K | -2.60K |
| Income Before Tax | -115.00K | -107.00K | -190.30K | -182.00K | -101.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.12 | -0.11 | -0.19 | -0.18 | -0.10 |
| Earnings from Discontinued Operations | -100.00 | -200.00 | -3.20K | -3.60K | -6.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -115.10K | -107.10K | -193.50K | -185.60K | -107.20K |
| EBIT | -12.40K | -9.10K | -92.50K | -82.90K | -2.60K |
| EBITDA | 52.00K | 54.80K | -30.40K | -21.30K | 58.40K |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 132.28M | 131.54M | 130.79M | 130.52M | 130.52M |
| Average Diluted Shares Outstanding | 132.28M | 131.54M | 130.79M | 130.52M | 135.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |